摘要
在过去二十年里,神经遗传的快速发展不仅在分子,病理,遗传方面,也在肌萎缩侧索硬化(ALS)的临床概念上发生了改变。 在这里,我们回顾了遗传性和散发性ALS中当前的遗传突破,并考虑到如何使得这些知识在可能的遗传疾病机制方案的拓展和更好的了解遗传、病理及临床亚型之间的关系。
关键词: 肌萎缩侧索硬化,痴呆,基因测试,全基因组关联,突变,表型,WES
Current Molecular Medicine
Title:Amyotrophic Lateral Sclerosis: A Genetic Point of View
Volume: 14 Issue: 8
Author(s): C. Carlesi, E. Caldarazzo Ienco, M. Mancuso and G. Siciliano
Affiliation:
关键词: 肌萎缩侧索硬化,痴呆,基因测试,全基因组关联,突变,表型,WES
摘要: In the last twenty years the rapid advances in neurogenetic have revolutionized not only the molecular, pathological, inheritance but also the clinical concept of ALS.
Here we review the current genetic breakthrough in familial and sporadic ALS, considering how this knowledge has allowed widening of the scenario on the possible pathogenic disease mechanisms and better understanding of the relationship between the genetic, pathological and clinical subtypes.
Export Options
About this article
Cite this article as:
Carlesi C., Ienco Caldarazzo E., Mancuso M. and Siciliano G., Amyotrophic Lateral Sclerosis: A Genetic Point of View, Current Molecular Medicine 2014; 14 (8) . https://dx.doi.org/10.2174/1566524014666141010155822
DOI https://dx.doi.org/10.2174/1566524014666141010155822 |
Print ISSN 1566-5240 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5666 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
CB1 Cannabinoid Receptors and their Associated Proteins
Current Medicinal Chemistry Oxidation Chemistry of Catecholamines and Neuronal Degeneration: An Update
Current Medicinal Chemistry Nanomedicine
Current Nanoscience CCL2-CCR2 Signaling in Disease Pathogenesis
Endocrine, Metabolic & Immune Disorders - Drug Targets Modelling Human Disease with Pluripotent Stem Cells
Current Gene Therapy Renin-Angiotensin-Aldosterone System: A Current Drug Target for the Management of Neuropathic Pain
Current Drug Targets Spinal Muscular Atrophy: Molecular Mechanisms
Current Molecular Medicine Gabapentin-Mediated Effects on Voltage- and Ligand-Gated Currents
Current Neuropharmacology Targeting Oxidative Stress Component in the Therapeutics of Epilepsy
Current Topics in Medicinal Chemistry Anti-Oxidants in Parkinson’s Disease Therapy: A Critical Point of View
Current Neuropharmacology Syntheses, Transformations and Pharmaceutical Applications of Kynurenic Acid Derivatives
Current Medicinal Chemistry Cellular Redox Modulator, ortho Mn(III) meso-tetrakis(N-n-Hexylpyridinium-2-yl)porphyrin, MnTnHex-2-PyP5+ in the Treatment of Brain Tumors
Anti-Cancer Agents in Medicinal Chemistry Serum Levels of Progranulin Do Not Reflect Cerebrospinal Fluid Levels in Neurodegenerative Disease
Current Alzheimer Research Role of Sirtuins and Calorie Restriction in Neuroprotection: Implications in Alzheimers and Parkinsons Diseases
Current Pharmaceutical Design Stem Cell Therapy: A Promising Approach in Treatment of COVID-19
Current Stem Cell Research & Therapy The Function of the Selective Inhibitors of Cycloxygenase 2
Mini-Reviews in Medicinal Chemistry On the Use of Hydrogels in Cell Encapsulation and Tissue Engineering Systems
Recent Patents on Drug Delivery & Formulation Recent Evidence of the Regulatory Role of PPARs in Neural Stem Cells and Their Underlying Mechanisms for Neuroprotective Effects
Current Stem Cell Research & Therapy The Interaction of DNA-Binding Ligands with Trinucleotide-Repeat DNA: Implications for Therapy and Diagnosis of Neurological Disorders
Current Topics in Medicinal Chemistry Prediction of Disease-Related Genes Based on Hybrid Features
Current Proteomics